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PDI, protein disulﬁde isomeraseAnterior Gradient 2 (AGR2) is a protein disulﬁde isomerase that plays important roles in diverse processes in
multiple cell lineages as a developmental regulator, survival factor and susceptibility gene for inﬂammatory
bowel disease. Here, we show using germline and inducible Agr2−/− mice that Agr2 plays important roles
in intestinal homeostasis. Agr2−/− intestine has decreased goblet cell Mucin 2, dramatic expansion of the
Paneth cell compartment, abnormal Paneth cell localization, elevated endoplasmic reticulum (ER) stress,
severe terminal ileitis and colitis. Cell culture experiments show that Agr2 expression is induced by ER stress,
and that siRNA knockdown of Agr2 increases ER stress response. These studies implicate Agr2 in intestinal
homeostasis and ER stress and suggest a role in the etiology of inﬂammatory bowel disease.
© 2009 Elsevier Inc. All rights reserved.Introduction
Anterior Gradient 2 (AGR2) is a developmental regulator and
survival factor with multiple functions that, although highly con-
served in evolution, remain poorly characterized. Originally charac-
terized in Xenopus laevis, heterologous AGR2 expression induces
ectopic cement gland differentiation and alters neuronal cell fate
(Aberger et al., 1998). In multiple mammalian cells, AGR2 stimulates
cell proliferation, cell adhesion, motility and inhibits apoptosis
(Fritzsche et al., 2006; Innes et al., 2006; Wang et al., 2008; Zhang
et al., 2007). AGR2 mRNA and protein occur at high levels in several
metastatic adenocarcinomas, e.g., colorectal, esophagus, prostate, and
breast, where it stimulates proliferation and inhibits apoptosis
(Fritzsche et al., 2007; Fritzsche et al., 2006; Innes et al., 2006;lasmic reticulum; PDI, protein
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ll rights reserved.Smirnov et al., 2005; Valladares-Ayerbes et al., 2008; Wang et al.,
2008; Zhang et al., 2007). In contrast, human AGR2 genetic variants
that decrease its expression are associated with increased risk of both
Crohn's disease and ulcerative colitis (Zheng et al., 2006).
Structurally, AGR2 is a member of the endoplasmic reticulum (ER)
protein disulﬁde isomerase (PDI) gene family (Park et al., 2009;
Persson et al., 2005). PDIs facilitate the isomerization of speciﬁc client
proteins into their bioactive conformations as they trafﬁc through the
ER for secretion or membrane association. When PDI substrates fail to
isomerize, misfolded membrane-associated and secreted proteins
accumulate in the ER, initiating ER stress, cell cycle arrest and
apoptosis. For example, AGR2 binds directly to Mucin 2 (Muc2), a
major component of intestinal mucus enabling the large number of
Muc2 Cys residues to pair correctly. Germline deletion of mouse Agr2
disrupts Muc2 protein stability and decreases intestinal mucus
production. However, Agr2 deﬁciency is reported only to cause
modest ER stress in the intestine and the impact of Agr2 deﬁciency
on the biology and functional state of additional intestinal cell
lineages is poorly characterized (Park et al., 2009).
The lower gastrointestinal tract consists of the small intestine and
colon. The lining epithelium of both organs is organized into crypts.
Undifferentiated stem and progenitor cells populate the base of small
intestine crypts and give rise to four major cell types: absorptive
enterocytes, goblet cells, Paneth cells and enteroendocrine cells
(Cheng and Leblond, 1974). Enterocytes absorb nutrients, secrete
hydrolytic enzymes into the intestinal lumen and are the most
271F. Zhao et al. / Developmental Biology 338 (2010) 270–279common intestinal cell type. Goblet cells produce mucous to protect
the intestinal barrier from inﬁltration by luminal contents. Paneth
cells protect against microbial infection and are located at the crypt
bottom. Enteroendocrine cells secrete a variety of hormones and are
relatively rare. Colonic crypts contain three major cell types, including
a higher proportion of goblet cells, somewhat fewer absorptive cells,
and scattered enteroendocrine cells.
In normal intestine, AGR2 is expressed in several cell types. These
include mature goblet, Paneth and enteroendocrine cells, as well as
Musashi-1 (MSI1)-positive intestinal stem/early progenitor cells and
proliferating secretory progenitors (Wang et al., 2008).
Intestinal epithelial cells are sensitive to ER stress. Targeteddeletion
in the mouse of the ER stress response transcription factor XBP1s, the
intestine-speciﬁc ER stress response sensor IRE1β, or mice carrying
missense mutations that impair Muc2 oligomerisation and protein
stability of Muc2, cause intestinal cell ER stress, cell cycle arrest,
apoptosis and chronic inﬂammation (Bertolotti et al., 2001; Heazle-
wood et al., 2008; Kaser et al., 2008). Therefore, based on its structure
and expression pattern, it was anticipated that AGR2might play a role
in the intestinal ER stress response and suppression of inﬂammation.
Here, we show using germline and inducible Agr2 knockout mice
and siRNA knock down in cell culture that Agr2 plays important roles
in intestinal goblet and Paneth cell homeostasis, Paneth cell
positioning and intestinal ER stress response. These data expand the
known roles played by Agr2 in homeostasis of the intestine.
Materials and methods
Generation of Agr2−/− mice
The gene-targeting strategy is described in supplementary
methods and summarized in Fig. 1. Mice were housed in a
temperature (∼21 °C) and humidity (∼55%)-controlled room in an
AALAC accredited vivarium with a 12 h light:12 h dark cycle. Entry
into the vivarium was restricted to appropriate personnel, but no SPF
precautions were available. Food pellets (Research Diets, New Jersey)
and water was available ad libitum.
Histology, immunohistochemistry and immunoﬂuorescence
Mouse intestines were removed and washed in cold phosphate-
buffered saline (PBS), ﬁxed by immersion in 4% paraformaldehyde,
embedded in parafﬁn, and 5 μm sections were applied to Probe-on
Plus™ slides (Fisher). For histology review, sections were stainedwith
hematoxylin and eosin or Alcian blue and nuclear fast red as detailed
in supplementary methods. For immunohistochemistry, primary
antibodies and according biotinylated secondary antibodies were
using. Staining was detected with Vectastain ABC reagent (PK-6100,
Vector) and development with DAB chromogen (DakoCytomation).
For immunoﬂuorescence, primary antibodies and according Texas red
or ﬂuorescein labeled secondary antibody were applied, then slides
were covered with Vectashield mounting medium with DAPI (H-
1200, Vector). For details and sources of antibodies, please refer to
supplementary methods.
BrdU labeling proliferation assay
To test proliferation, mice were injected 2 h before sacriﬁce with
BrdU labeling reagent. Tissues were processed and the BrdU labeling
cell proliferation assay were performed according to the manufac-
turer's protocol (BrdU labeling and Detection Kit I, Roche).
Epithelial RNA isolation and quantiﬁcation
Sheets of small intestinal epithelium were separated from
underlying lamina propria using 3 mM EDTA, 0.5 mM DTT in PBS(Whitehead et al., 1993). Brieﬂy, mouse intestine was removed,
opened and washed in PBS 3 changes. The linearized intestine was
decontaminated by soaking in 0.04% (vol/vol) sodium hypochlorite in
PBS for 20 min at room temperature, then incubated in 3mM EDTA
plus 0.5mM DTT in PBS at 22 °C for 90 min with occasional gentle
stirring. The digestion mixture of the intestine was resuspended in
PBS and epithelium detached by vigorous shaking in a sealed
container. Intestinal epithelium was harvested by centrifuge at
1000 rpm for 5 min. Total RNA isolated using Qiagen RNAeasy
columns was reverse transcribed to cDNA by using cDNA Kit (Applied
Biosystems). qRT-PCR was performed using an ABI 7900HT-Sequen-
ceDetection System with SYBR Green Master Mix. For quantitative
analysis, all samples were normalized to Gapdh expression using the
ΔΔCT value method. Gene-speciﬁc primers refer to supplementary
methods.
Western blot
Samples were separated by SDS/PAGE and transferred to Immo-
bilon-P PVDF (Millipore). Membranes were blocked with 5% nonfat
dry milk and incubated overnight at 4 °C with primary antibodies.
Band was detected by chemiluminesence using HRP-conjugated
secondary antibody and ECL Western blotting reagents (GE
Healthcare).
Puriﬁcation and analysis of Cryptdin peptides
Cryptdin peptides were isolated using modiﬁed procedures
described previously (Mastroianni and Ouellette, 2009; Selsted et al.,
1992). Ilea were excised from seven inducible Agr2−/− mice (after
4 days of tamoxifen administration) and seven wild type mice (also
received tamoxifen administration for 4 days). Protein extracts were
prepared from “complete” ileum, consisting of tissue plus luminal
contents. Details refer to supplementary methods.
XBP1 splicing assay
XBP1 splicingwasmeasured by speciﬁc primers (Kaser et al., 2008)
ﬂanking the splicing site yielding PCR product sizes of 164 and 138 bp
for human XBP1u and XBP1s, and 171 and 145 bp for mouse Xbp1.
Products were resolved on 2% agarose gels and band intensity was
determined densitometrically.
Cell line and small interfering RNA (siRNA) transient transfections
Pancreatic cancer cell line, Su.86.86 (American Type Culture
Collection) and ON-TARGETplus SMARTpool Human siRNA-AGR2
and Non-targeting Pool control scrambled siRNA (siRNA-Scr)
(Dharmacon, Inc.) were used. Details are described in supplemen-
tary methods.
SuperArray screening
Epithelial RNA was converted to cDNA using RT² ﬁrst strand kit
(SABioscience, C-03). Real-time PCR was done using SuperArray
RT² SYBR Green qPCR Master Mix (SABioscience, PA-012-12) and
SuperArray RT² Proﬁler™ PCR Array (PAMM-077). Thermal cycling
parameters were 95 °C for 10 min, followed by 40 cycles of
ampliﬁcations at 95 °C for 15 s, 60 °C for 60 s. Data were analyzed
by PCR Array Data Analysis Web Portal using the default set
format.
In situ hybridization
Mouse ileum was ﬁxed in 4% paraformaldehyde at 4 °C overnight,
then transferred to 30% sucrose solution and incubated at 4 °C
overnight, ﬁnally frozen in OCT compound and stored at -80 °C. In situ
Fig. 1. Generation of Agr2−/−mice. (A) Gene-targeting strategy. The four alleles used in the gene targeting of Agr2 are shown. Black boxes with numbers denote Agr2 exons. PGK-
Neo, neomycin resistance cassette, is shown as a yellow box. Blue arrows show LoxP sites. Red arrows P1–P3 depict PCR primer locations. Deletion of exons 2, 3 and 4 produces a
frame shift in exon 5. (B) Breeding strategies for germline and inducible Agr2 knockout mice. Flox, ﬂanking LoxP site. PRM-Cre, protamine promoter driven Cre recombinase. Tam-
Cre, tamoxifen inducible Cre recombinase. (C) PCR products from different Agr2 genotypes. Mouse tail DNA was PCR ampliﬁed using three primers whose locations are shown in
Panel A. The wild-type allele produced a band of 280 bp, the ﬂoxed allele a band of 335 bp and the null allele a band of 519 bp. (D) DNA sequencing of cDNA showing the junction of
exons 1 and 5 in the Agr2−/− intestine epithelium. (E) Western analysis shows a 19.9-kDa band speciﬁc for Agr2 absent in Agr2−/− mice. β-actin is used as a protein loading
control. (F) Immunohistochemistry for Agr2 in small intestine. Agr2 protein is stained dark brown. (a) wild type; (b) germline Agr2−/−; (c) inducible Agr2−/−.
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(Abzhanov et al., 2003). Details refer to supplementary methods.
Results
Generation of germline and inducible Agr2−/− mice
To understand the mechanistic roles of Agr2we created a Cre-LoxP
inducible Agr2 knockout mouse model (Fig. 1A). To generate a
germline Agr2−/− mice we crossed Protamine-Cre transgenic mice
(O'Gorman et al., 1997) (Tg PRM-Cre) that deletes Agr2 in the male
germline. For detailed breeding strategies, see Fig. 1B. We thenFig. 2. Paneth cell abnormalities in germline and inducible Agr2−/− mice. (A) H+E-stain
(day 5). Paneth cells containing brightly eosinophilic granules are dramatically expanded i
are easily visible in the inducible Agr2−/− small intestine. Representative crypt bases are b
propria mononuclear inﬁltrates can also be seen in the inducible Agr2−/− small intestin
germline Agr2−/− mice. Multiple Paneth cells are ectopically located in the upper crypt
40×closeup image reveals characteristic Paneth cell granules that are cryptdin 5-positive
Agr2−/− small intestine (day 6). TaqMan analysis of Sox9 mRNA in small intestine of ind
to 1.0. Mean bars of standard error are shown. The indicated P-values were determined
extracted from distal small intestine of inducible Agr2−/− mice (day 4). Bradford assays
from separations of inducible Agr2−/− and Wt P-60 fractions. Cryptdin P-60 fractions we
protein was determined by adding the protein in non-cryptdin containing fractions to the
between inducible Agr2−/− and Wt mice are listed.intercrossed Agr2 ﬂox/− mice to make Agr2−/− mice. To generate
inducible Agr2−/− mice, we used the Rosa26-CreER strain that has
tightly controlled and inducible systemic Cre recombinase activation
with tamoxifen (Badea et al., 2003). We crossed the Rosa26-CreER (Tg
Tam-Cre) with Agr2 ﬂox/ﬂox to create Agr2ﬂox/ﬂox;TgTam-Cremice to
create inducible Agr2−/− mice. Agr2ﬂox/ﬂox;TgTam-Cre mice ex-
press Agr2 until mice are injected with tamoxifen (Garcia and Mills,
2002). For both germline and inducible Agr2−/− mice, deletions of
exons 2, 3 and 4 were conﬁrmed by sequencing of cDNA converting
from RNA isolated from intestine epithelia (Fig. 1D). Agr2 protein was
undetectable as assayed by western blotting and IHC (Figs. 1E, F). Our
models are therefore a null allele.ed sections of small intestine from wild type, germline and inducible Agr2−/− mice
n both germline and inducible Agr2−/− mice. Intralumenal Paneth cell granule casts
oxed in green and shown at 20× and 40× magniﬁcations. A marked increase in lamina
e. (B) Abnormally positioned Paneth cells in the upper crypt and villus epithelium of
(green arrows). A Paneth cell located on the villus is indicated by a green circle. A
by immunohistochemistry. (C) Increased Paneth cell marker Sox9 mRNA in inducible
ucible Agr2−/− and wild type mice. Wild-type Sox9 mRNA expression is normalized
by Student t-test. (D) Increased relative amount of cryptdins in the total protein
were performed to quantitate the amount of total protein in individual P-60 fractions
re those that appeared to contain mainly cryptdins by AU-PAGE. The total amount of
protein in cryptdin containing fractions. Relative differences in the protein quantities
Fig. 3. Severe ileitis and colitis in germline Agr2−/− mice. (A) H&E staining reveals
severe acute ileitis, with a dense, primarily neutrophilic inﬁltrate in the lamina propria
and submucosa. Inset reveals neutrophils surrounding hypertrophied Paneth cells. (B)
Acute colitis in the proximal colon, with loss of goblet cells, crypt elongation, and
inﬁltrating neutrophils (inset). (C) Florid lymphoid hyperplasia of ileal Peyer's patches,
with multinucleated giant cells (white arrows). (D) Multinucleated giant cells
suggestive of granulomatous inﬂammation in interfollicular zones are seen at higher
power (inset, lower right).
274 F. Zhao et al. / Developmental Biology 338 (2010) 270–279Dramatically decreased Mucin 2 in goblet cells from germline and
inducible Agr2−/− mice
To analyze the phenotype in GI tract of Agr2−/− mice, we
performed H+E staining which showed that germline and inducible
Agr2−/− mice lack morphologically normal goblet cells (Supple-
mentary Fig. 1A, B, C). Next, we performed Alcian Blue staining. Alcian
Blue detects acid mucopolysaccharides and glycosaminoglycans,
which are normally restricted to pre-goblet and goblet cells. Staining
of wild type small intestine revealed numerous Alcian Blue-positive
cells (Supplementary Fig. 1D). By contrast, virtually no Alcian Blue-
positive cells were observed in either germline or inducible Agr2−/−
mice(Supplementary Fig. 1E, F). Immunohistochemistry revealed that
MUC2 protein was dramatically reduced, but detectable (Supplemen-
tary Fig. 1G, H, I). In contrast, the goblet cell marker intestinal trefoil
factor (ITF) was not reduced in germline Agr2−/− mice (Supple-
mentary Fig. 1J, K). No signiﬁcant differences in intestinal enteroendo-
crine cell chromogranin A were seen (Supplementary Fig. 1S, T, U). In
summary, the goblet cell lineage continues to exist in both germline
and inducible Agr2−/− small intestine but these cells lose their
normal morphology and cannot be identiﬁed by H&E or Alcian blue
staining.
Multiple Paneth cell abnormalities in Agr2−/− mice
Paneth cells are specialized epithelial cells that mediate innate
mucosal immunity against enteric microbial infections. Localized at
the base of the crypts of Lieberkühn in the small intestine, Paneth cells
release large, apically-oriented dense-core secretory granules contain-
ing cryptdins and other host defense molecules (Porter et al., 2002).
Dramatic expansion of Paneth cell compartmentwas consistently seen
in all regions of the small intestine both in the germline and inducible
Agr2−/− mice (Fig. 2A) (Supplementary Fig. 2). These cells contain-
ing large, dense eosinophilic granules were conﬁrmed to be Paneth
cellswith immunostudies ofmarkers cryptdin-5,MMP7, lysozyme and
Sox9 (Supplementary Figs. 1, 3). Cells immunopositive for these
Paneth cell markers were detected in wild type small intestine and
limited to the bottom of crypts. These cells comprised a visibly greater
proportion of the crypt base in both germline (Supplementary Fig. 1N,
Q) and inducible (Supplementary Fig. 1O, R) Agr2−/− intestine. To
conﬁrm these studies, we examined Sox9 mRNA expression, which is
elevated more than ﬁve-fold (Fig. 2C) and mature cryptdin peptides,
which are elevatedmore than three-fold vs. wild typemice (Fig. 2D) in
inducible Agr2−/− intestine. Additionally, cells containing large,
dense eosinophilic granules are abnormally positioned in the villi of
germline Agr2−/− small intestine. Cells with dense large granules are
also immunopositive for Paneth cell markers cryptdin-5, MMP7,
lysozyme and Sox9 (Fig. 2B and Supplementary Fig. 3).
Terminal ileitis and colitis in Agr2−/− mice
To deﬁne in more detail the normal Agr2 expression pattern in
wild-type mice, we analyzed the entire lower GI tract by immuno-
histochemistry and Western blot analysis. Agr2 is expressed in all
regions of small intestine and colon. Highest expression is in the ileum
and colon (Supplementary Fig. 4). In both germline and inducible
Agr2−/− mice, in addition to Paneth cell compartment expansion
and decreased Mucin 2 expression in goblet cells we see profound
inﬂammatory inﬁltrates in the lamina propria and submucosa. The
inﬂammation is most severe in the terminal ileum, and to a lesser
extent in the colon. In the germline Agr2−/− mice, the terminal
ileitis is characterized by a dense neutrophilic inﬁltrate surrounding
both crypt bases and submucosal perivascular spaces (Fig. 3A, inset).
There is marked follicular hyperplasia of the Peyer's patches, which
also have numerous multinucleated giant cells in the interfollicular
areas, suggestive of granulomatous inﬂammation (Figs. 3C, D,arrows). Germline deletion of Agr2 in the colon causes colitis,
characterized by a mixed acute and chronic inﬂammatory inﬁltrate
expanding the isolated lymphoid follicles and the lamina propria.
There is signiﬁcant neutrophil inﬁltration and marked crypt hyper-
plasia (Fig. 3B). No inﬂammation or other abnormalities were seen in
Tam-Cre mice without the Agr2 ﬂox/ﬂox alleles (data not shown). In
summary, both germline and inducible Agr2−/−mice have dramatic
inﬂammation of the intestine, most notably the ileum, and colon.
Paneth cell abnormalities precede those of goblet cells and enterocytes
Because germline Agr2−/−mice have a dramatic increase in both
Paneth cells and inﬂammation, it could not be deﬁned whether
Paneth cell expansionwas a primary response to acute Agr2 deﬁciency
or a response to inﬂammation and bacterial invasion from a
compromised intestinal epithelial barrier. To resolve this issue, we
ﬁrstly analyzed the inducible Agr2−/−model at multiple time points
after induced deletion. After inducing Agr2 knockout, the ﬁrst
observable defect is Paneth cell expansion 24 h after tamoxifen
injection (day 1) (Fig. 4A). Importantly, this Paneth cell abnormality
precedes any histologic signs of inﬂammation. Subsequently, normal
goblet cells are lost and acute inﬂammatory inﬁltrates invade the
lamina propria, along with a further increase in the Paneth cell
compartment (day 3). Next, enterocyte homeostasis is disrupted as
the remaining absorptive enterocytes become dysplastic and the villi
are blunted (day 5). To test further whether 24 h after Agr2 deletion
there is an early inﬂammatory response that could explain the
observed Paneth cell expansion, we analyzed expression of MUC2,
acid mucins (with Alcian blue staining) and 82 key genes involved in
mouse inﬂammatory responses using SuperArray proﬁling. Compared
to wild type mice, MUC2 immunoﬂuorescence and Alcian blue
staining at this time point are not changed (Supplementary Fig. 5),
and SuperArray proﬁling reveals only one signiﬁcantly dysregulated
gene (Nos2) 24 h after Agr2 deletion in small intestine epithelium
(Supplementary Fig. 6). However, on day 5 after Agr2 deletion, when
Fig. 4. Sequential abnormalities in morphology in the intestine of inducible Agr2−/− mice. (A) H&E staining shows sequential abnormalities of Paneth cells, goblet cells and
enterocytes in inducible Agr2−/− small intestine. Representative crypt bases are boxed in green and shown at 20× and 40× magniﬁcations. Agr2 Tam-Cre ﬂox/ﬂox mice were
injected with tamoxifen and mice analyzed over 1, 3 and 5 days. Day 0 (same day as tamoxifen injection), no visible abnormality. Day 1, crypt Paneth cell compartment expansion is
seen, while goblet cells and enterocytes are unremarkable. Day 3, decrease in morphologically normal goblet cells, enterocyte dysplasia, further Paneth cell expansion and lamina
propria inﬂammation is seen. Day 5, complete loss of morphologically normal goblet cells, severe loss of enterocytes, appearance of Paneth cell casts and increased lamina propria
inﬂammation. (B) BrdU staining shows decreased proliferation in inducible Agr2−/− small intestine and colon (day 6). Mice were injected with BrdU and sacriﬁced 2 h after
injection. Small intestine (top) and colon (bottom) were visualized with ﬂuorescence microscopy. (Left) Immunoﬂuorescence of BrdU (green) labeled crypts from Wt and induced
Agr2−/− mice. (Right) Number of BrdU positive cells per crypt in small intestine (top) and colon (bottom) of Wt mice and inducible Agr2−/− mice. (C) Caspase 3 assay shows
increased apoptosis in inducible Agr2−/− small intestine and colon (day 6). Mean bars of standard error are shown. The indicated P-values were determined by Student t-test.
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blue staining of acid mucins are dramatically decreased (Supplemen-
tary Fig. 1I,F) and 47 out of 82 SuperArray proﬁled genes are
dysregulated (data not shown). To test whether the impact of Agr2
deletion on enterocytes is caused by decreased proliferation or
increased apoptosis, we performed BrdU and caspase 3 staining of
wild type and induced Agr2−/− small intestine and colon. By day 6,
the induced Agr2 deletion caused signiﬁcantly less proliferation and
increased apoptosis in all regions of the small intestine and colon
(Figs. 4B, C). In summary, the ﬁrst observable defect after Agr2
induced knockout is Paneth cell hypertrophy and expansion followed
by loss of visible goblet cells, and subsequent decreased enterocyte
proliferation and increased apoptosis.Increased ER stress in Agr2 knockout intestine and siRNA
knockdown cells
Based on its structure and expression pattern, it was originally
anticipated that AGR2 might play a role in the intestinal ER stress
response. However, in a previous study of Agr2−/− mice, only
modestly increased ER stress markers at the mRNA level were found
(Park et al., 2009). The ER chaperone BiP and the spliced form of Xbp1
(Xbp1s) are well characterized biomarkers of ER stress (Ron and
Walter, 2007). Therefore, we analyzed their expression in Agr2−/−
intestinal epithelial preps. BiP protein levels were dramatically
increased in germline Agr2−/− small intestine (Fig. 5A). To explore
the expression pattern of BiP in small intestine, we ﬁrst performed in
Fig. 5. Agr2 knockout increases ER stress in the intestine. (A) Germline Agr2−/− small intestine has increased levels of the ER stress response marker BiP. Agr2 protein and actin
loading control are shown below. (B) Inducible Agr2−/− small intestine (day 6) has increased ER stress response marker Xbp1s. Agr2 deletion was induced with tamoxifen and
small intestine was assayed for Xbp1s mRNA on day 6. Xbp1u, unspliced, full length form of Xbp1. Xbp1s, spliced form that is induced by ER stress. (C) Increased ER stress marker
mRNA expression in induced Agr2−/−mice (day 6). qPCR of ER stress biomarker expression levels of Chop, Pdia3 and Perk. mRNA expressions of wild type are normalized to 1.0.
Mean bars of standard error are shown. The indicated P-values were determined by Student t-test.
276 F. Zhao et al. / Developmental Biology 338 (2010) 270–279situ hybridization by using a digoxigenin-labeled antisense RNA probe
and a sense control probe speciﬁc for BiP. In wild type mice, the
hybridization signal was detected in epithelial cells of the middle and
upper crypts and at crypt-villus junctions (Supplementary Fig. 7A). In
germline Agr2−/− mice, increased signal intensity was evident in
the same regions as wild type mice but also extending into the lower
regions of crypts and villi (Supplementary Fig. 7B). Additionally,
certain epithelial cells with increased BiP hybridization signals were
seen in the upper villus regions (Supplementary Fig. 7B, black arrows)
as well as in cells adjacent to Paneth cells near and at the base of
crypts (Supplementary Fig. 7F). No detectable signals were detected
at the upper villi or crypt base of wild type mice (Supplementary Fig.
7E). As Agr2 is normally expressed in multiple cell types including all
three mature secretory cell lineages andMSI1-positive intestinal stem
cells/early progenitor cells (Wang et al., 2008), we performed co-
immunoﬂuorescence studies to understand which cell types experi-
ence ER stress. BiP protein is increased is MSI1-positive cells at the
crypt base (Supplementary Fig. 8A, white arrow) and lower crypt
proliferative zone (Supplementary Fig. 8B, white arrows). Addition-
ally, both ITF-positive goblet cells and abnormally positioned MMP7-Fig. 6. AGR2 siRNA knock down increases ER stress. (A) AGR2 is an ER stress response gene.W
stress inducer tunicamycin (0, 2.5, 5 and 7.5 μM) and probed with anti-AGR2 (Top) and anti-G
biomarker BiP in tunicamycin treated cells. Western blot analysis of SU86.86 cells treated w
BiP (Top). Beta-actin is included as a loading control (Middle). AGR2, Anterior gradient 2 (b
probed on the same transferred gel. SiRNA-Scr, negative control scrambled siRNA. SiRNA-AG
isoforms in SU 86.86 cells. AGR2 siRNA knockdown induces XBP1s levels in SU 86.86 cells. Ce
higher levels than siRNA-Scr, Pb0.001. Standard error of the mean is shown. The indicatedpositive Paneth cells on villi have increased BiP protein (Supplemen-
tary Fig. 8C,D). In summary, protein levels of the ER stress marker BiP
are increased in MSI1-positive intestinal stem/early progenitor cells
as well as in cells on villi that are immunopositive for goblet cell and
Paneth cell lineage markers.
To examine ER stress in more detail, we analyzed other markers. In
wild type mice, Xbp1u mRNA was detectable but Xbp1s mRNA level
was not. In contrast, Xbp1s mRNA was expressed in Agr2−/− mice
(Fig. 5B). mRNA levels for additional ER stress response markers Chop,
Pdia3 and Perk also were elevated (Fig. 5C). Because the intestine has
a complex physiology and is populated with many different cell types,
we could not determine whether the impact of Agr2 deletion directly
or indirectly increases intestinal ER stress. To conﬁrm the observa-
tions in Agr2−/− intestine and test whether Agr2 plays a direct role
in this process, we used a different experimental approach, siRNA
knockdown studies in cell culture. First, we tested whether AGR2 is an
ER stress response gene. In SU86.86 cells, baseline AGR2 protein levels
are low. Tunicamycin is a well characterized inhibitor of ER protein
glycosylation and inducer of ER stress. Treatment with tunicamycin
signiﬁcantly increases AGR2 protein levels (Fig. 6A). Next, we lookedestern blot analysis of SU86.86 cells in culture treated with increasing amounts of the ER
APDH as a loading control (bottom). (B) AGR2 siRNA knockdown increases the ER stress
ith 2.5 μM tunicamycin and transfected with anti-AGR2 siRNA. BiP, ER stress biomarker
ottom). BiP, beta-actin and AGR2 all have different electrophoretic mobilities and were
R2, AGR2 speciﬁc siRNA (Open biosystems). (C, D) RT-PCR of XBP1 unspliced and spliced
lls were treated with tunicamycin at 5 μM, siRNA-AGR2 increases XBP1s levels to much
P-values were determined by Student t-test.
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In untreated cells transfected with control scrambled siRNA, protein
levels of the ER stress biomarker BiP are low (Fig. 6B). siRNA
knockdown of AGR2 in cells effectively decreases AGR2 protein levels,
but does not affect basal BiP levels. As expected, treatmentwith the ER
stress inducer tunicamycin increases BiP levels. siRNA knockdown of
AGR2 in tunicamycin treated cells further increases BiP protein levels.
Consistent with Fig. 6A, AGR2 protein levels are also induced by
tunicamycin, while control β-actin levels are not. Next, we tested for
XBP1s. As expected, tunicamycin increases the ratio of spliced (active
in ER stress) to unspliced XBP1 (XBP1s/u). siRNA knockdown in
untreated cells only slightly increased the XBP1s/u ratio. However, in
the presence of tunicamycin, siRNA knockdown of Agr2 signiﬁcantly
increased the XBP1s/u ratio (Figs. 6C, D).
Discussion
AGR2 is an evolutionarily highly conserved protein disulﬁde
isomerase whose roles include stimulation of cell proliferation,
adhesion, motility, anti-apoptosis, Muc2 protein folding and devel-
opmental cell fate (Aberger et al., 1998; Fritzsche et al., 2007, 2006;
Innes et al., 2006; Smirnov et al., 2005; Valladares-Ayerbes et al.,
2008; Wang et al., 2008; Zhang et al., 2007). In the intestine, AGR2 is
strongly expressed in several distinct cell types, including the three
differentiated intestinal secretory cell lineages, goblet cell progenitors
andMSI1-positive intestinal stem cells/early progenitors (Wang et al.,
2008). Because of this expression pattern and the fact that each
protein disulﬁde isomerase is thought to have multiple client
substrates, it was originally anticipated that AGR2 would play diverse
roles in multiple intestinal cell types. Our experiments indicate that
the absence of Agr2 can lead to abnormalities in multiple intestinal
cell types and increased ER stress. A recent study using germline
Agr2−/− mice showed that this gene plays an essential role in the
production of intestinal mucus by goblet cells(Park et al., 2009).
However, in the absence of exogenous agents, there were no other
abnormalities in intestinal physiology, homeostasis, or inﬂammation
of the small intestine or colon noted. In our study, we generated
germline and inducible Agr2−/−mouse models. Consistent with this
study (Park et al., 2009), our germline and inducible Agr2−/− mice
have virtually no morphologically normal goblet cells and decreased
intestinal mucus. Also consistent with this study, the goblet cell
lineage still exists and there is no apparent enteroendocrine cell
phenotype. However, in contrast to the previous study, we observe
several additional abnormalities. These include dramatic intestinal
Paneth cell abnormalities and severe intestinal inﬂammation in the
absence of treatment with any exogenous agents. The Paneth cell
expansion occurs along thewhole small intestine and ismost dramatic
in the ileum. Extracellular Paneth cell granule aggregations and even
casts commonly occur. Consistent with expansion of the Paneth cell
compartment, expression of differentiated Paneth cell markers Sox9
and cryptdin-5 are dramatically elevated.
Another abnormality in the germline Agr2−/− mice is misloca-
lized Paneth cells away from the crypt base into the upper crypt and
villi. This abnormal Paneth cell location phenotype is also seen in
mouse knockouts of the WNT signaling components Frizzled 5, EphB3
and Apc that help specify proper cell location along the crypt-villus
axis (Andreu et al., 2008; Batlle et al., 2002; van Es et al., 2005).
Because Sox9 is a feedback inhibitor of WNT signaling, it is possible
that the increased Sox9 expression in Agr2−/− intestine inhibits
Frizzled 5, EphB3 or Apc expression and/or activity to cause
inappropriate Paneth cell migration. Future studies with inducible
Sox9 transgenic mice may help to answer this question. Because
Paneth cells can respond to inﬂammation, we performed a time
course with inducible Agr2−/− mice to determine if inﬂammation
preceded the Paneth cell increase or the reverse sequence was
occurring. Expansion of the Paneth cell compartment is the ﬁrstmorphological abnormality caused by induced Agr2 deﬁciency and
precedes any signs of intestinal inﬂammation or decreased intestinal
mucus production. In summary, while we cannot exclude a low level
inﬂammatory response 24 h after Agr2 induced deletion that we did
not detect is responsible for the expansion of the Paneth cell
compartment, our data are most consistent with Paneth cell
abnormalities being the ﬁrst observable change from induced Agr2
deletion, followed by loss of normal goblet cells and mucin secretion.
Future studies will be required to address whether expansion of the
Paneth cell compartment truly is a primary effect of induced Agr2
deletion, or if inﬂammation below the detection level of our studies is
causing this expansion. Because a recent study observed the
morphological loss of goblet cells without any Paneth cell abnormal-
ities, the mechanism of Agr2 action to inhibit goblet cell mucus
production and impair normalmorphology is likely to be distinct from
that causing Paneth cell expansion. This interpretation is also
consistent with previous observations that transgenic ablation of
goblet cells does not cause spontaneous inﬂammation or Paneth cell
expansion (Itoh et al., 1999), both of which are seen in Agr2−/−
mice. Finally, in the inducible Agr2−/−model, subsequent to Paneth
and goblet cell abnormalities and inﬂammation, enterocyte homeo-
stasis is disrupted with decreased proliferation, increased apoptosis
and blunting of villi. Because Sox9 knockout in intestinal epithelium
causes increased enterocyte proliferation, hyperplasia and Paneth cell
loss (the opposite of the Agr2−/− phenotype), it is possible these
effects are mediated through increased levels of Sox9 in inducible
Agr2−/− mice. However, given the delay in enterocyte abnormali-
ties, these effects may well be secondary to problems occurring in
other cell types rather than a primary effect of Agr2 deﬁciency. Future
studies with intestinal cell type speciﬁc Agr2 deletion will be helpful
to resolve this issue. We do not see abnormally positioned Paneth cell
in the inducible Agr2−/− mice, nor do not see decreased prolifer-
ation or increased apoptosis of enterocytes in the germline Agr2−/−
mice. The reasons for these differences are not clear at present. With
regard to the Paneth cell location, the acute signiﬁcant disruption of
crypt-villus architecture in the inducible Agr2−/− mice may
preclude abnormal Paneth cell migration or differentiation in the
upper crypt and villus, if it were to occur. With regard to decreased
proliferation and increased apoptosis of enterocytes and overall
disruption of crypt-villus architecture in the inducible but not
germline Agr2−/− mice, we speculate that this difference may
reﬂect a gradual upregulation of other protein disulﬁde isomerases
during development in the germline knockout mice that compensate
for the loss of Agr2. However, with inducible Agr2 knockout, intestinal
cells cannot compensate for the acute loss. The lack of acute
compensation causes increased cellular apoptosis and decreased
proliferation. Future studies to identify other protein disulﬁde
isomerases that can compensate for Agr2 loss may help to resolve
this issue.
Our Agr2−/− mice develop severe acute terminal ileitis with
multinucleated giant cells reminiscent of granulomatous inﬂamma-
tion. Overall, our ﬁndings in the germline knockouts are similar to that
seen in human Crohn's disease. In molecular epidemiology studies,
AGR2 genetic variants that decrease its mRNA expression are
associated with increased risk of both Crohn's disease and ulcerative
colitis(Zheng et al., 2006). While there are multiple mouse models
used for the study of ulcerative colitis(Byrne and Viney, 2006; Jurjus
et al., 2004) to our knowledge only TNFΔARE and SAMP1/Yit mice are
currently used as models of Crohn's disease (Bamias et al., 2007).
Therefore, further studies of Agr2−/− mice may be particularly
helpful to improve our mechanistic understanding of Crohn's disease
etiology. ER stress causes cells to arrest proliferation and initiate
apoptosis. Targeted deletion of the mouse ER stress response
transcription factor Xbp1, the GI epithelial speciﬁc ER stress response
gene Ire1β or mice carrying missensemutations in Muc2 andMtbtps1
that increase GI epithelial cell ER stress cause decreased intestinal
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(Bertolotti et al., 2001; Brandl et al., 2009; Heazlewood et al., 2008;
Kaser et al., 2008). Protein disulﬁde isomerases relieve ER stress and
Agr2 was previously speculated to play a role in the ER stress
response (Persson et al., 2005). In our Agr2−/− mice, we ﬁnd
elevated intestinal levels of ER stress. ER stress is high in proliferating
MSI1-positive intestinal stem cell/early progenitor cells, ITF-positive
goblet lineage cells andMMP7-positive abnormally positioned Paneth
cells in the villus in Agr2−/− small intestine. Surprisingly, there is no
increased ER stress in themature Paneth cells at the crypt base. Future
experiments with cell lineage speciﬁc Agr2 knockout mice will be
necessary to understand more precisely the role of Agr2 in the
different intestinal cell types, and whether these are the same cells
experiencing ER stress in Xbp1, Ire1β, Muc2 and Mtbtps1 mouse
models of inﬂammatory bowel disease. Additionally, these experi-
ments will help address the role of cell autonomous and non-cell
autonomous increased ER stress in the intestine.
To conﬁrm whether Agr2 deﬁciency increases ER stress, and test
whether this effect is a direct rather than indirect consequence of Agr2
deﬁciency, we performed siRNA knockdown of Agr2 in cell culture.
We found Agr2 protein levels increase in response to ER stress and
that Agr2 knockdown causes increased ER stress levels in cells treated
with the ER stress inducer tunicamycin.
In the previous study of Agr2−/− mice, the authors concluded
that ER stress was not signiﬁcantly elevated in this model. However,
in their model the intestinal inﬂammation was not seen in the small
intestine and extremely mild in the colon in the absence of treatment
with the colitis inducer DSS(Park et al., 2009). It is not clear at
present why in our Agr2−/− mouse lines intestinal inﬂammation is
more severe, and several intestinal cell types are affected, compared
to only goblet cell Muc2 production and increased DSS sensitivity in
the line developed previously. In our model, we engineered deletion
of Agr2 exons 2–4, while the other group deleted exons 2–3. We also
cannot exclude differences in genetic background as a potential
cause. For example, the C57B/L6 strain is largely resistant to
intestinal inﬂammation by DSS and in Muc2−/− mice the colitis
phenotype arises only on a permissive genetic background (Velcich
et al., 2002). However, perhaps a more likely explanation is that the
mice generated previously were housed in a germ-free barrier
facility while our mice were not. Therefore, it is tempting to
speculate that commensal ﬂora in our Agr2−/− colony contribute
to the broader expressivity and increased severity of the pathology,
most notably in the development of terminal ileitis. Commensal
microﬂora have been suggested to worsen the severity of terminal
ileitis in the SAMP1/YitFc model of Crohn's disease (Bamias et al.,
2007). This speculation would be consistent with our cell culture
studies as well, where Agr2 knockdown in isolation did not much
affect basal ER stress levels but had a signiﬁcant effect when cells
were treated exogenously with an ER stress inducing agent. Future
studies that examine Agr2−/− intestinal inﬂammation in germ free
conditions with exposure to individual, well characterized strains of
commensal bacteria will be helpful to address this question. Since
human AGR2 genetic variants that decrease its expression are
associated with increased risk of Crohn's disease and ulcerative
colitis (Zheng et al., 2006), further experiments studying gene/
environment interactions in Agr2−/− mice and cells may well
provide important insights into the etiology of Crohn's disease and
ulcerative colitis.
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